Appendix 1: Chemical and Physical Characteristics of Vitamins
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Recent Insights Into the Role of Vitamin B12 and Vitamin D Upon Cardiovascular Mortality: a Systematic Review
Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 2 Issue 12 December 2018 Review Article Recent Insights into the Role of Vitamin B12 and Vitamin D upon Cardiovascular Mortality: A Systematic Review Raja Chakraverty1 and Pranabesh Chakraborty2* 1Assistant Professor, Bengal School of Technology (A College of Pharmacy), Sugandha, Hooghly, West Bengal, India 2Director (Academic), Bengal School of Technology (A College of Pharmacy),Sugandha, Hooghly, West Bengal, India *Corresponding Author: Pranabesh Chakraborty, Director (Academic), Bengal School of Technology (A College of Pharmacy), Sugandha, Hooghly, West Bengal, India. Received: October 17, 2018; Published: November 22, 2018 Abstract since the pathogenesis of several chronic diseases have been attributed to low concentrations of this vitamin. The present study Vitamin B12 and Vitamin D insufficiency has been observed worldwide at all stages of life. It is a major public health problem, throws light on the causal association of Vitamin B12 to cardiovascular disorders. Several evidences suggested that vitamin D has an effect in cardiovascular diseases thereby reducing the risk. It may happen in case of gene regulation and gene expression the vitamin D receptors in various cells helps in regulation of blood pressure (through renin-angiotensin system), and henceforth modulating the cell growth and proliferation which includes vascular smooth muscle cells and cardiomyocytes functioning. The present review article is based on identifying correct mechanisms and relationships between Vitamin D and such diseases that could be important in future understanding in patient and healthcare policies. There is some reported literature about the causative association between disease (CAD). Numerous retrospective and prospective studies have revealed a consistent, independent relationship of mild hyper- Vitamin B12 deficiency and homocysteinemia, or its role in the development of atherosclerosis and other groups of Coronary artery homocysteinemia with cardiovascular disease and all-cause mortality. -
Download Leaflet View the Patient Leaflet in PDF Format
Read all of this leaflet carefully before you are given this within the body usually caused by diseases of the gut, liver any other medicines. Driving and using machines medicine because it contains important information for or gall bladder. • Medicines for heart disease such as digoxin or verapamil as Ergocalciferol may cause drowsiness or your eyes to you. It is important that you have this medicine so that your these can cause high levels of calcium in the blood leading become very sensitive to light. If this happens to you, do bones and teeth form properly. • Keep this leaflet. You may need to read it again. to an irregular or fast heart beat. not drive or use machinery. • If you have any further questions, ask your doctor or nurse. 2. What you need to know before you are given • Antacids containing magnesium for indigestion. If you are 3. How you will be given Ergocalciferol • If you get any side effects, talk to your doctor or nurse. Ergocalciferol on kidney dialysis this can lead to high levels of Ergocalciferol will be given to you by your doctor or nurse. This includes any possible side effects not listed in this magnesium in the blood which causes muscle weakness, Important: Your doctor will choose the dose that is right leaflet. See section 4. You must not be given Ergocalciferol: low blood pressure, depression and coma. for you. In this leaflet, Ergocalciferol 300,000 IU Injection BP will • if you are allergic to ergocalciferol (vitamin D) or any of the other • Thiazide diuretics (‘water tablets’) to relieve water You will be given Ergocalciferol by your doctor or nurse as an injection into a muscle. -
Cosmeceutical Products List
PROVEDA HERBALS Manufacturer of: - Soaps, Shampoos, Creams, Lotions, Gels, Hair Oil etc. Unit: - Plot no. 42, 43 Sector 2, Sidcul, IIE, BHEL, Ranipur, Haridwar, Uttrakhand, India Corporate office : A 42,Ashoka Crescent Road, DLF Phase 1, Gurugram, Haryana-122002 Website : www.provedaherbal.com, www.tbcbynature.in LIST OF COSMECEUTICALS PRODUCTS FACE WASH S.NO. PRODUCT NAME ACTIVE INGREDIENTS SKIN REJUVENATING & GLYCOLIC ACID, LACTIC ACID, VITAMIN-E, D-PANTHENOL (VITAMIN-B5), ALOEVERA 1 LIGHTENING FACE WASH WITH EXTRACT, GLYCERIN MILLIGLOBULES ANTI ACNE FACE WASH TEA TREE OIL, SALICYLIC ACID, ALOEVERA EXTRACT, VITAMIN-E, D-PANTHENOL, 2 WITH MILLIGLOBULES GLYCERIN & EXCIPIENTS NEEM ANTI-BACTERIAL FACE 3 NEEM OIL, ALOEVERA EXTRACT, TEA TREE OIL, AMLA EXTRACT WASH WITH MILLIGLOBULES ALOEVERA FACE WASH WITH 4 ALOEVERA EXTRACT, CUCUMBER EXTRACT, VITAMIN- E, D- PANTHENOL, ALLANTOIN CUCUMBER ALOEVERA FACE WASH WITH 5 ALOEVERA EXTRACT, WHEAT GERM EXTRACT, D-PANTHENOL, GLYCERIN MILLIGLOBULES SKIN LIGHTENING FACE WASH ARBUTIN, VITAMIN-B3 & E, GLYCOLIC ACID, LICORICE EXTRACT, AMLA EXTRACT, 6 WITH MILLIGLOBULES GLYCERIN, D-PANTHENOL 7 PAPAYA FACE WASH ALOEVERA EXTRACT, PAPAIN ENZYME, GLYCERIN, , D-PANTHENOL, VITAMIN-E 8 SALICYLIC ACID FACE WASH SALICYLIC ACID, TEA TREE OIL, ALOE VERA EXTRACT SHAMPOO ALOEVERA & VITAMIN-E ALOEVERA EXTRACT, VITAMIN-E, D-PANTHENOL, POLYQUATERNIUM-10, LEMON PEEL 1 SHAMPOO EXTRACT 2 MULTIVITAMIN SHAMPOO ALOEVERA, VITAMIN-E, D-PANTHENOL, POLYQUATERNIUM-10, LEMON PEEL EXTRACT PROTEIN & VITAMIN SHAMPOO SUN FLOWER SEED OIL, -
Folic Acid, Pyridoxine, and Cyanocobalamin Combination
ORIGINAL INVESTIGATION Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women The Women’s Antioxidant and Folic Acid Cardiovascular Study William G. Christen, ScD; Robert J. Glynn, ScD; Emily Y. Chew, MD; Christine M. Albert, MD; JoAnn E. Manson, MD Background: Observational epidemiologic studies indi- and visually significant AMD, defined as confirmed in- cate a direct association between homocysteine concentra- cident AMD with visual acuity of 20/30 or worse attrib- tion in the blood and the risk of age-related macular degen- utable to this condition. eration (AMD), but randomized trial data to examine the effect of therapy to lower homocysteine levels in AMD are Results:Afteranaverageof7.3yearsoftreatmentandfollow- lacking. Our objective was to examine the incidence of AMD up, there were 55 cases of AMD in the combination treat- in a trial of combined folic acid, pyridoxine hydrochloride ment group and 82 in the placebo group (relative risk, 0.66; (vitamin B6), and cyanocobalamin (vitamin B12) therapy. 95% confidence interval, 0.47-0.93 [P=.02]). For visually significant AMD, there were 26 cases in the combination Methods: We conducted a randomized, double-blind, treatment group and 44 in the placebo group (relative risk, placebo-controlled trial including 5442 female health care 0.59; 95% confidence interval, 0.36-0.95 [P=.03]). professionals 40 years or older with preexisting cardio- vascular disease or 3 or more cardiovascular disease risk Conclusions: These randomized trial data from a large factors. A total of 5205 of these women did not have a cohort of women at high risk of cardiovascular disease diagnosis of AMD at baseline and were included in this indicate that daily supplementation with folic acid, pyri- analysis. -
R Graphics Output
Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 ) -
Spectator Anion Seems to Alter the Hazard Index Only Marginally. Significant Differences in Asthmagenicity Are Not Observed Betw
STATEMENT OF INTEREST TABLE 1 Hazard indices of common vitamin compounds None declared. Vitamin Molecular mass Da Hazard index REFERENCES All-trans retinoic acid (A) 300.44 0.9329 1 Retinyl palmitate (A) 524.88 0.9974 Sripaiboonkij P, Phanprasit W, Jaakkola MS. Respiratory beta-carotene (provitamin A) 536.89 0.9970 effects of occupational exposures in a milk powder factory. Eur Respir J 2008; 31: 807–814. Ergocalciferol (D2) 396.66 0.9432 2 Drought VJ, Francis HC, Niven RMcL, Burge PS., Cholecalciferol (D3) 384.65 0.9355 Tocopherol acetate (E) 472.76 0.9036 Occupational asthma induced by thiamine in a vitamin Naphthoquinone (K) 158.16 0.1600 supplement for breakfast cereals. Allergy 2005; 60: 1213–1214. 3 Jarvis J, Seed MJ, Elton R, Sawyer L, Agius R. Relationship Phylloquinone (K1) 116.16 0.1157 between chemical structure and the occupational asthma Menaquinone (K2) 168.15 0.2958 Menadione (Provitamin K) 172.19 0.2044 hazard of low molecular weight organic compounds. Occup Environ Med 2005; 62: 243–250. Thiamine (B1) 263.34 0.9400 4 Seed MJ, Agius RM. Prediction of asthma hazard of Thiamine hydrochloride (B1) 338.28 0.9469 thiamine. Allergy 2006; 61: 648. Thiamine mononitrate (B1) 329.38 0.9548 Riboflavin (B2) 376.37 0.9987 DOI: 10.1183/09031936.00065108 Niacin (B3) 123.11 0.9169 Pantothenic acid (B5) 219.24 0.9896 Pyridoxine (B ) 169.18 0.0963 6 From the authors: Pyridoxine hydrochloride (B6) 205.64 0.0948 Biotin (H/B7) 244.31 0.9631 We recently reported results of a cross-sectional study of 167 Folic acid (B9) 441.41 1.0000 milk powder factory workers and 76 office workers from # Cyanocobalamin (B12) 1355.37 Thailand showing that production and packing workers Ascorbic acid (C) 176.13 0.0196 exposed to relatively low concentrations of milk powder experienced significantly increased risk of nasal symptoms #: high molecular weight unsuitable for quantitative structural activity and breathlessness, had clearly increased risk of wheezing and relationship model. -
Antioxidants During Your Radiation Therapy
Form: D-5021 What You Need to Know About Taking Antioxidants During Your Radiation Therapy For patients getting radiation therapy Read this brochure to know: • should you take antioxidants during radiation treatment • which vitamins and supplements are safe to take during radiation therapy • what are food sources with antioxidants • where to get more information What are antioxidants? Antioxidants are nutrients found in some foods and also in supplements such as pills. Antioxidants help your body protect your cells from damage and help your body repair damage to your cells. They are good for normal cells because they help repair and prevent damage. Should I take antioxidants during radiation therapy? The goal of radiation therapy is to damage your cancer cells. Antioxidants may prevent your radiation treatment from being as effective because they may protect your cancer cells. Avoid taking large amounts of antioxidants during your radiation therapy treatment. Avoid taking these antioxidant pills in large amounts such as: • vitamin C • vitamin E • beta carotene • selenium Look at the side of your supplement or multivitamin bottle to check the amount of antioxidants. Below is a table of safe amounts of antioxidants you can take while having treatment. Do not take more than the amount listed. Name of antioxidant Do NOT take more than: Vitamin C 90 milligrams per day for men 75 mg per day for women Vitamin E natural Vitamin E (d-alpha- 22 IU per day tocopherol) synthetic Vitamin E (dl- 33 IU per day alpha-tocopherol) Selenium 55 micrograms per day Beta carotene Avoid because there is no safe level IU = International Unit 2 The safe amounts of antioxidants listed in the table come from Health Canada. -
Sodium Ascorbate Powder USP MSDS Material Safety Data Sheet
Sodium Ascorbate Powder USP MSDS Material Safety Data Sheet NFPA HMIS Personal Protective Equipment Health Hazard 1 1 1 0 Fire Hazard 1 Reactivity 0 See Section 15. Section 1. Chemical Product and Company Identification Page Number: 1 Common Name/ Sodium ascorbate Catalog S1137, SO108, S1349 Trade Name Number(s). CAS# 134-03-2 Manufacturer SPECTRUM LABORATORY PRODUCTS INC. RTECS CI7671000 14422 S. SAN PEDRO STREET TSCA TSCA 8(b) inventory: Sodium GARDENA, CA 90248 ascorbate Commercial Name(s) Ascorbicin, Ascorbin, Cebitate, Natrascorb CI# Not available. Synonym Sodium L-Ascorbate; Vitamin C Sodium; IN CASE OF EMERGENCY L-Ascorbic acid sodium salt; CHEMTREC (24hr) 800-424-9300 Ascorbic acid sodium salt; Monosodium L-Ascorbate Chemical Name L-Ascorbic Acid, monsodium salt Chemical Family Not available. CALL (310) 516-8000 Chemical Formula C6H7NaO6 Supplier SPECTRUM LABORATORY PRODUCTS INC. 14422 S. SAN PEDRO STREET GARDENA, CA 90248 Section 2.Composition and Information on Ingredients Exposure Limits Name CAS # TWA (mg/m 3) STEL (mg/m 3) CEIL (mg/m 3) % by Weight 1) Sodium ascorbate 134-03-2 100 Toxicological Data Sodium ascorbate : on Ingredients ORAL (LD50): Acute: 17531 mg/kg [Mouse]. 16300 mg/kg [Rat]. Section 3. Hazards Identification Potential Acute Health Effects Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Potential Chronic Health CARCINOGENIC EFFECTS : Not available. Effects MUTAGENIC EFFECTS : Mutagenic for mammalian somatic cells. TERATOGENIC EFFECTS : Not available. DEVELOPMENTAL TOXICITY : Not available. The substance may be toxic to kidneys, bladder. Repeated or prolonged exposure to the substance can produce target organs damage. -
Guidelines on Food Fortification with Micronutrients
GUIDELINES ON FOOD FORTIFICATION FORTIFICATION FOOD ON GUIDELINES Interest in micronutrient malnutrition has increased greatly over the last few MICRONUTRIENTS WITH years. One of the main reasons is the realization that micronutrient malnutrition contributes substantially to the global burden of disease. Furthermore, although micronutrient malnutrition is more frequent and severe in the developing world and among disadvantaged populations, it also represents a public health problem in some industrialized countries. Measures to correct micronutrient deficiencies aim at ensuring consumption of a balanced diet that is adequate in every nutrient. Unfortunately, this is far from being achieved everywhere since it requires universal access to adequate food and appropriate dietary habits. Food fortification has the dual advantage of being able to deliver nutrients to large segments of the population without requiring radical changes in food consumption patterns. Drawing on several recent high quality publications and programme experience on the subject, information on food fortification has been critically analysed and then translated into scientifically sound guidelines for application in the field. The main purpose of these guidelines is to assist countries in the design and implementation of appropriate food fortification programmes. They are intended to be a resource for governments and agencies that are currently implementing or considering food fortification, and a source of information for scientists, technologists and the food industry. The guidelines are written from a nutrition and public health perspective, to provide practical guidance on how food fortification should be implemented, monitored and evaluated. They are primarily intended for nutrition-related public health programme managers, but should also be useful to all those working to control micronutrient malnutrition, including the food industry. -
Vitamin B12 Vitamin D Iodine and Selenium
Frequently Asked Questions for VEG 1 General 1. Why has VEG 1 been developed? VEG 1 was developed to provide a convenient way of avoiding the most common weak points in a varied vegan diet: vitamin B12, iodine, vitamin D and selenium. Vitamin B12 Vitamin B12 is almost entirely absent from modern plant foods which are not contaminated by bacteria and insects. Even unwashed, organically grown plants do not contain a significant amount of B12. Vegans often have intakes of vitamin B12 well below recommended intakes. Low vitamin B12 intake by vegans routinely leads to reduced activity of some important enzymes and increased levels of homocysteine and methylmalonic acid (MMA). Even moderately elevated homocysteine is associated with increased risk of death, depression, stroke, dementia and birth defects, though it remains unclear how many of these associations reflect true cause and effect. Vegans who do not get vitamin B12 from fortified food or supplements are at increased risk of clinical deficiency symptoms such as anaemia and nervous system damage. The most common early symptoms of vitamin B12 deficiency are tiredness (from anaemia), numbness and tingling (from nervous system damage) and sore tongue. VEG 1 is designed to provide sufficient absorbed vitamin B12 to match national and international recommended intakes. It is designed to be chewed as this increases the reliability of vitamin B12 absorption by dispersing and dissolving the tablet. Vitamin D In the winter – whenever our shadows at midday are more than twice as long as we are – our skin cannot produce vitamin D effectively and even small dietary intakes may become important to avoid deficiency. -
Vitamin and Mineral Requirements in Human Nutrition
P000i-00xx 3/12/05 8:54 PM Page i Vitamin and mineral requirements in human nutrition Second edition VITPR 3/12/05 16:50 Page ii WHO Library Cataloguing-in-Publication Data Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements (1998 : Bangkok, Thailand). Vitamin and mineral requirements in human nutrition : report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. 1.Vitamins — standards 2.Micronutrients — standards 3.Trace elements — standards 4.Deficiency diseases — diet therapy 5.Nutritional requirements I.Title. ISBN 92 4 154612 3 (LC/NLM Classification: QU 145) © World Health Organization and Food and Agriculture Organization of the United Nations 2004 All rights reserved. Publications of the World Health Organization can be obtained from Market- ing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permis- sion to reproduce or translate WHO publications — whether for sale or for noncommercial distri- bution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; e-mail: [email protected]), or to Chief, Publishing and Multimedia Service, Information Division, Food and Agriculture Organization of the United Nations, 00100 Rome, Italy. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. -
Directory of Us Bean Suppliers · Quality Grown in the Usa
US DRY DIRECTORY OF US BEAN SUPPLIERS · QUALITY GROWN IN THE USA BEANENGLISH SUPPLIERS DIRECTORY DRY BEANS FROM THE USA edn ll R ryn ma ber avyn eyn S an N idn inkn Cr K P ed R rk a D hernn yen ort cke dneyn zon N Bla Ki ban man at d ar Li e Re G ge r t ar G L h ig L ton Pin Liman ckn y Bla iman n ab y L dzuki B ab A B n e re G U.S. DRY BEANS www.usdrybeans.com International Year of the Pulse 2016 · www.iyop.net 01 n Pink Adzuki Large Lima Pink Garbanzo Dark Red Kidney Great Northern an Lim ge ar L Small Red Navy Black Baby Lima Blackeye Light Red Kidney in dzuk A Green Baby Lima Pinto Cranberry TABLE OF CONTENTS About the US Dry Bean Council 2 US Dry Bean Council Overseas Representatives 3 USDBC Members and Producers Organisations4 Major US Dry Bean Classes 6 Dry Bean Production Across the US 8 Companies by Bean Class 10 Alphabetical Listing Of US Dry Bean Suppliers 14 Nutritional Value 34 About the US Dry Bean Industry 36 USDBC Staff 37 02 ABOUT THE US DRY BEAN COUNCIL (USDBC) The USDBC is a trade association comprised of leaders in the bean industry with the common goal of educating US consumers about the benefits of beans. The USDBC gives a voice to the bean industry and provides information to consumers, health professionals, educators USDBC USA and the media about the good taste, nutritional value and Rebecca Bratter, Executive Director versatility of beans.